Clinical Trials Logo

Clinical Trial Summary

To investigate the pharmacokinetic Drug-drug interaction


Clinical Trial Description

The purpose of this study is to investigate the pharmacokinetic Drug-Drug(telmisartan, amlodipine and/ or rosuvastatin) interaction and safety in healthy male volunteers. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02233218
Study type Interventional
Source Yuhan Corporation
Contact
Status Completed
Phase Phase 1
Start date July 2014
Completion date January 2015

See also
  Status Clinical Trial Phase
Completed NCT01442532 - A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam Phase 1
Completed NCT01133431 - The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea Phase 1
Completed NCT00859352 - AZD1981 Midazolam CYP4503A Induction Study Phase 1
Completed NCT01776047 - A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers Phase 1